Blood plasma research points to Pfizer jab being less effective against Omicron
Scientists say more studies are needed as the body's total immune response could tell a different story
08 December 2021 - 14:30
UPDATED 08 December 2021 - 20:02
Preliminary research conducted in a laboratory on blood plasma from people who had received two doses of the Pfizer vaccine has shown that it provides less immunity to the Omicron variant than the ancestral variant of the coronavirus found in China about two years ago.
As at Tuesday, 26.6-million vaccine doses had been administered, of which 20-million were Pfizer shots...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.